Literature DB >> 18650461

Human natural killer cells.

Michael A Caligiuri1.   

Abstract

Natural killer (NK) cells were discovered more than 30 years ago. NK cells are large granular lymphocytes that belong to the innate immune system because unlike T or B lymphocytes of the adaptive or antigen-specific immune system, NK cells do not rearrange T-cell receptor or immunoglobulin genes from their germline configuration. During the past 2 decades there has been a substantial gain in our understanding of what and how NK-cells "see," lending important insights into their functions and purpose in normal immune surveillance. The most recent discoveries in NK-cell receptor biology have fueled translational research that has led to remarkable results in treating human malignancy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18650461      PMCID: PMC2481557          DOI: 10.1182/blood-2007-09-077438

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  117 in total

Review 1.  Natural killer cells: from CD3(-)NKp46(+) to post-genomics meta-analyses.

Authors:  Thierry Walzer; Sébastien Jaeger; Julie Chaix; Eric Vivier
Journal:  Curr Opin Immunol       Date:  2007-04-17       Impact factor: 7.486

2.  Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value.

Authors:  Loredana Ruggeri; Antonella Mancusi; Marusca Capanni; Elena Urbani; Alessandra Carotti; Teresa Aloisi; Martin Stern; Daniela Pende; Katia Perruccio; Emanuela Burchielli; Fabiana Topini; Erika Bianchi; Franco Aversa; Massimo F Martelli; Andrea Velardi
Journal:  Blood       Date:  2007-03-19       Impact factor: 22.113

3.  CD56brightCD16- killer Ig-like receptor- NK cells display longer telomeres and acquire features of CD56dim NK cells upon activation.

Authors:  Chiara Romagnani; Kerstin Juelke; Michela Falco; Barbara Morandi; Antonella D'Agostino; Roberta Costa; Giovanni Ratto; Giuseppe Forte; Paolo Carrega; Gabrielle Lui; Romana Conte; Till Strowig; Alessandro Moretta; Christian Münz; Andreas Thiel; Lorenzo Moretta; Guido Ferlazzo
Journal:  J Immunol       Date:  2007-04-15       Impact factor: 5.422

Review 4.  Cutaneous T-cell and NK-cell lymphomas: the WHO-EORTC classification and the increasing recognition of specialized tumor types.

Authors:  Marsha C Kinney; Dan Jones
Journal:  Am J Clin Pathol       Date:  2007-05       Impact factor: 2.493

5.  Transforming growth factor beta 1 inhibits expression of NKp30 and NKG2D receptors: consequences for the NK-mediated killing of dendritic cells.

Authors:  Roberta Castriconi; Claudia Cantoni; Mariella Della Chiesa; Massimo Vitale; Emanuela Marcenaro; Romana Conte; Roberto Biassoni; Cristina Bottino; Lorenzo Moretta; Alessandro Moretta
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-19       Impact factor: 11.205

6.  Disulphide-isomerase-enabled shedding of tumour-associated NKG2D ligands.

Authors:  Brett K Kaiser; Daesong Yim; I-Ting Chow; Segundo Gonzalez; Zhenpeng Dai; Henning H Mann; Roland K Strong; Veronika Groh; Thomas Spies
Journal:  Nature       Date:  2007-05-09       Impact factor: 49.962

7.  Cytomegalovirus evasion of innate immunity by subversion of the NKR-P1B:Clr-b missing-self axis.

Authors:  Sebastian Voigt; Aruz Mesci; Jakob Ettinger; Jason H Fine; Peter Chen; Wayne Chou; James R Carlyle
Journal:  Immunity       Date:  2007-04-26       Impact factor: 31.745

8.  Identification, activation, and selective in vivo ablation of mouse NK cells via NKp46.

Authors:  Thierry Walzer; Mathieu Bléry; Julie Chaix; Nicolas Fuseri; Lionel Chasson; Scott H Robbins; Sébastien Jaeger; Pascale André; Laurent Gauthier; Laurent Daniel; Karine Chemin; Yannis Morel; Marc Dalod; Jean Imbert; Michel Pierres; Alessandro Moretta; François Romagné; Eric Vivier
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-20       Impact factor: 11.205

Review 9.  Interferon: cellular executioner or white knight?

Authors:  S G Maher; A L Romero-Weaver; A J Scarzello; A M Gamero
Journal:  Curr Med Chem       Date:  2007       Impact factor: 4.530

10.  CD56bright human NK cells differentiate into CD56dim cells: role of contact with peripheral fibroblasts.

Authors:  Antoni Chan; Deng-Li Hong; Ann Atzberger; Simon Kollnberger; Andrew D Filer; Christopher D Buckley; Andrew McMichael; Tariq Enver; Paul Bowness
Journal:  J Immunol       Date:  2007-07-01       Impact factor: 5.422

View more
  673 in total

1.  Natural killer cell engineering for cellular therapy of cancer.

Authors:  D R Shook; D Campana
Journal:  Tissue Antigens       Date:  2011-12

2.  Cell-to-cell contact with hepatitis C virus-infected cells reduces functional capacity of natural killer cells.

Authors:  Joo Chun Yoon; Jong-Baeck Lim; Jeon Han Park; Jae Myun Lee
Journal:  J Virol       Date:  2011-09-21       Impact factor: 5.103

3.  Differential impact of inhibitory and activating Killer Ig-Like Receptors (KIR) on high-risk patients with myeloid and lymphoid malignancies undergoing reduced intensity transplantation from haploidentical related donors.

Authors:  D-F Chen; V K Prasad; G Broadwater; N L Reinsmoen; A DeOliveira; A Clark; K M Sullivan; J P Chute; M E Horwitz; C Gasparetto; G D Long; Y Yang; N J Chao; D A Rizzieri
Journal:  Bone Marrow Transplant       Date:  2011-12-05       Impact factor: 5.483

Review 4.  Umbilical cord blood immunology: relevance to stem cell transplantation.

Authors:  Syh-Jae Lin; Dah-Chin Yan; Yen-Chang Lee; Hsiu-Shan Hsiao; Pei-Tzu Lee; Yu-Wen Liang; Ming-Ling Kuo
Journal:  Clin Rev Allergy Immunol       Date:  2012-02       Impact factor: 8.667

5.  Natural killer cell-produced IFN-γ and TNF-α induce target cell cytolysis through up-regulation of ICAM-1.

Authors:  Ruipeng Wang; Jessica J Jaw; Nicole C Stutzman; Zhongcheng Zou; Peter D Sun
Journal:  J Leukoc Biol       Date:  2011-11-01       Impact factor: 4.962

6.  FISH-Flow, a protocol for the concurrent detection of mRNA and protein in single cells using fluorescence in situ hybridization and flow cytometry.

Authors:  Riccardo Arrigucci; Yuri Bushkin; Felix Radford; Karim Lakehal; Pooja Vir; Richard Pine; December Martin; Jeffrey Sugarman; Yanlin Zhao; George S Yap; Alfred A Lardizabal; Sanjay Tyagi; Maria Laura Gennaro
Journal:  Nat Protoc       Date:  2017-05-18       Impact factor: 13.491

7.  A phase 1 trial of the anti-KIR antibody IPH2101 in patients with relapsed/refractory multiple myeloma.

Authors:  Don M Benson; Craig C Hofmeister; Swaminathan Padmanabhan; Attaya Suvannasankha; Sundar Jagannath; Rafat Abonour; Courtney Bakan; Pascale Andre; Yvonne Efebera; Jérôme Tiollier; Michael A Caligiuri; Sherif S Farag
Journal:  Blood       Date:  2012-10-01       Impact factor: 22.113

8.  MICA-Expressing Monocytes Enhance Natural Killer Cell Fc Receptor-Mediated Antitumor Functions.

Authors:  Amanda R Campbell; Megan C Duggan; Lorena P Suarez-Kelly; Neela Bhave; Kallan S Opheim; Elizabeth L McMichael; Prashant Trikha; Robin Parihar; Eric Luedke; Adrian Lewis; Bryant Yung; Robert Lee; David Raulet; Susheela Tridandapani; Veronika Groh; Lianbo Yu; Vedat Yildiz; John C Byrd; Michael A Caligiuri; William E Carson
Journal:  Cancer Immunol Res       Date:  2017-07-19       Impact factor: 11.151

Review 9.  Advances in targeted therapy for malignant lymphoma.

Authors:  Li Wang; Wei Qin; Yu-Jia Huo; Xiao Li; Qing Shi; John E J Rasko; Anne Janin; Wei-Li Zhao
Journal:  Signal Transduct Target Ther       Date:  2020-03-06

Review 10.  Immunobiology of hepatocarcinogenesis: Ways to go or almost there?

Authors:  Pavan Patel; Steven E Schutzer; Nikolaos Pyrsopoulos
Journal:  World J Gastrointest Pathophysiol       Date:  2016-08-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.